View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
FRIDAY, July 4 (HealthDay News) -- A nurse-delivered intervention -- Depression Care for People with Cancer -- may be a beneficial and cost-effective strategy for managing major depressive disorder in patients with cancer and other medical disorders, according to an article published in the July 5 issue of The Lancet.
Vanessa Strong, Ph.D., of the University of Edinburgh Cancer Research Centre and Western General Hospital in Edinburgh, U.K., and colleagues randomly assigned 200 depressed cancer patients (mean age 56.6 years) with a prognosis of more than six months to either the intervention or usual care.
After three months, the researchers found that the adjusted difference in mean Symptom Checklist-20 depression scores was 0.34 between the intervention and usual care groups. They also unexpectedly found that this treatment effect was sustained at six and 12 months. They calculated that the intervention would cost $10,556 per quality-adjusted life-year gained.
"In further trials (SMaRT oncology 2 and 3), we aim to investigate whether Depression Care for People with Cancer is cost effective if implemented on a large scale and if screening, training of nurses, and other costs are fully assessed and whether this intervention can also benefit patients who have cancers with poor prognoses, such as lung cancer," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top